Carlsbad, California
United States
177
2026-05-28
The entities that hold a legal rights for patent applications filed by inventor Seth Punit P.:
Punit P. Seth from Carlsbad, US has applied for patents for these inventions. The list has both pending applications and granted patents:
COMPOSITIONS AND METHODS FOR ENHANCED INTESTINAL ABSORPTION OF CONJUGATED OLIGOMERIC COMPOUNDS
#2 | 2026-02-05COMPOSITIONS AND METHODS FOR MODULATING APOLIPOPROTEIN C-III EXPRESSION
#3 | 2026-01-22Compositions and Methods for Modulating Complement Factor B Expression
#4 | 2025-12-11Selective Antisense Compounds and Uses Thereof
#5 | 2025-12-04Linkage Modified Oligomeric Compounds and Uses Thereof
#6 | 2025-11-20Modified Compounds and Uses Thereof
#7 | 2025-11-13CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE
#8 | 2025-10-30Conjugated Antisense Compounds and Their Use
#9 | 2025-08-28Selective Antisense Compounds and Uses Thereof
#10 | 2025-08-21Linkage Modified Oligomeric Compounds
#11 | 2025-06-05COMPOUNDS AND METHODS FOR MODULATING SMN2
#12 | 2025-05-15LINKAGE MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF
#13 | 2024-12-05COMPOSITIONS AND METHODS FOR MODULATING PKK EXPRESSION
#14 | 2024-12-05COMPOSITIONS AND METHODS FOR MODULATING APOLIPOPROTEIN C-III EXPRESSION
#15 | 2024-11-21CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF
#16 | 2024-11-07Selective Antisense Compounds and Uses Thereof
#17 | 2024-10-31LINKAGE MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF
#18 | 2024-10-24Compositions and methods for modulating apolipoprotein (a) expression
#19 | 2024-10-03ALLELE-SELECTIVE COMPOUNDS AND METHODS FOR MODULATING HUNTINGTIN EXPRESSION
#20 | 2024-09-12COMPOUNDS AND METHODS FOR REDUCING APP EXPRESSION
#21 | 2024-09-05Selective Antisense Compounds and Uses Thereof
#22 | 2024-09-05GLP-1 RECEPTOR LIGAND MOIETY CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF
#23 | 2024-08-22Conjugated antisense compounds and their use
#24 | 2024-07-25CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE
#25 | 2024-05-02Selective Antisense Compounds and Uses Thereof
#26 | 2024-03-21COMPOSITIONS AND METHODS FOR ENHANCED INTESTINAL ABSORPTION OF CONJUGATED OLIGOMERIC COMPOUNDS
#27 | 2024-01-04LINKAGE MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF
#28 | 2023-11-23COMPOUNDS AND METHODS FOR MODULATING PMP22
#29 | 2023-11-09COMPOSITIONS AND METHODS FOR MODULATING COMPLEMENT FACTOR B EXPRESSION
#30 | 2023-10-26CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF
#31 | 2023-05-25MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF
#32 | 2023-05-18COMPOSITIONS AND METHODS FOR MODULATING TTR EXPRESSION
#33 | 2023-04-20COMPOSITIONS AND METHODS FOR MODULATING GROWTH HORMONE RECEPTOR EXPRESSION
#34 | 2023-04-13Selective Antisense Compounds and Uses Thereof
#35 | 2023-03-30OLIGOMERIC COMPOUNDS COMPRISING BACKBONE CONSTRAINED MACROCYCLES
#36 | 2023-03-02Modified compounds and uses thereof
#37 | 2023-02-23Compositions and methods for modulating complement factor B expression
#38 | 2023-01-05Selective antisense compounds and uses thereof
#39 | 2022-10-13COMPOSITIONS AND METHODS FOR MODULATING ANGIOPOIETIN-LIKE 3 EXPRESSION
#40 | 2022-09-01COMPOSITIONS AND METHODS FOR MODULATING TTR EXPRESSION
#41 | 2022-06-16Linkage modified oligomeric compounds and uses thereof
#42 | 2022-04-12Conjugated antisense compounds and their use
#43 | 2022-03-17Compounds and Methods for Use in Dystrophin Transcript
#44 | 2022-03-10COMPOUNDS AND METHODS FOR MODULATION OF SMN2
#45 | 2022-03-03MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF
#46 | 2022-01-27CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE
#47 | 2022-01-06COMPOUNDS AND METHODS FOR MODULATING ANGIOTENSINOGEN EXPRESSION
#48 | 2021-12-23COMPOSITIONS AND METHODS FOR MODULATING APOLIPOPROTEIN C-III EXPRESSION
#49 | 2021-12-09CHIRALLY ENRICHED OLIGOMERIC COMPOUNDS
#50 | 2021-11-11GLP-1 receptor ligand moiety conjugated oligonucleotides and uses thereof
#51 | 2021-11-11Allele specific modulators of P23H rhodopsin
#52 | 2021-10-14Compounds and Methods for Modulation of Transcript Processing
#53 | 2021-09-09Compositions and methods for modulating PKK expression
#54 | 2021-08-26Modified compounds and uses thereof
#55 | 2021-08-19LINKAGE MODIFIED OLIGOMERIC COMPOUNDS
#56 | 2021-08-05Selective antisense compounds and uses thereof
#57 | 2021-07-08Compositions and methods for modulating growth hormone receptor expression
#58 | 2021-05-20Selective Antisense Compounds and Uses Thereof
#59 | 2021-05-06COMPOSITIONS AND METHODS
#60 | 2021-03-25Compositions and methods for modulating apolipoprotein (a) expression
#61 | 2021-02-25CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE
#62 | 2021-02-25CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE
#63 | 2021-01-28COMPOSITIONS AND METHODS FOR MODULATING TTR EXPRESSION
#64 | 2021-01-21Modified compounds and uses thereof
#65 | 2021-01-07Selective antisense compounds and uses thereof
#66 | 2020-12-17Conjugated antisense compounds and their use
#67 | 2020-12-105′ modified nucleosides and oligomeric compounds prepared therefrom
#68 | 2020-08-27GLP-1 RECEPTOR LIGAND MOIETY CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF
#69 | 2020-07-30Morpholino modified oligomeric compounds
#70 | 2020-07-16COMPOSITIONS AND METHODS FOR MODULATING HBV EXPRESSION
#71 | 2020-05-21COMPOSITIONS AND METHODS FOR ENHANCED INTESTINAL ABSORPTION OF CONJUGATED OLIGOMERIC COMPOUNDS
#72 | 2020-04-23Compositions and methods for modulating growth hormone receptor expression
#73 | 2020-03-05Allele specific modulators of P23H rhodopsin
#74 | 2020-02-20SELECTIVE ANTISENSE COMPOUNDS AND USES THEREOF
#75 | 2020-02-20COMPOSITIONS AND METHODS FOR MODULATING PKK EXPRESSION
#76 | 2020-02-13COMPOSITIONS AND METHODS FOR MODULATING COMPLEMENT FACTOR B EXPRESSION
#77 | 2019-12-05Conjugated antisense compounds and their use
#78 | 2019-11-28Oligomeric compounds comprising α-β-constrained nucleic acid
#79 | 2019-11-07SELECTIVE ANTISENSE COMPOUNDS AND USES THEREOF
#80 | 2019-10-31COMPOUNDS AND METHODS FOR USE IN DYSTROPHIN TRANSCRIPT
#81 | 2019-10-24COMPOUNDS AND METHODS FOR MODULATION OF SMN2
#82 | 2019-10-24COMPOUNDS AND METHODS FOR MODULATION OF TRANSCRIPT PROCESSING
#83 | 2019-09-12SELECTIVE ANTISENSE COMPOUNDS AND USES THEREOF
#84 | 2019-09-05Antisense compounds and uses thereof
#85 | 2019-07-11Method for synthesis of reactive conjugate clusters
#86 | 2019-05-30Compounds and methods for modulating angiotensinogen expression
#87 | 2019-05-09GLP-1 Receptor Ligand Moiety Conjugated Oligonucleotides and Uses Thereof
#88 | 2019-02-21COMPOSITIONS AND METHODS FOR MODULATING HBV EXPRESSION
#89 | 2019-01-17Compositions and methods for modulating angiopoietin-like 3 expression
#90 | 2018-12-27Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom
#91 | 2018-11-08COMPOSITIONS AND METHODS FOR MODULATING GROWTH HORMONE RECEPTOR EXPRESSION
#92 | 2018-10-25Linkage modified oligomeric compounds
#93 | 2018-10-18TARGETED THERAPEUTIC NUCLEOSIDES AND THEIR USE
#94 | 2018-09-27Compositions and methods for modulating apolipoprotein (a) expression
#95 | 2018-09-27Compositions and methods for modulating apolipoprotein C-III expression
#96 | 2018-09-13Conjugated antisense compounds and their use
#97 | 2018-08-30COMPOSITIONS AND METHODS FOR ENHANCED INTESTINAL ABSORPTION OF CONJUGATED OLIGOMERIC COMPOUNDS
#98 | 2018-06-21Allele specific modulators of P23H rhodopsin
#99 | 2018-02-15Compositions and methods for modulating TTR expression
#100 | 2018-01-11ANTISENSE COMPOUNDS AND USES THEREOF
177023 ⎘